Park Ha Biological Technology (BYAH) Long-Term Investments (2023 - 2026)

Park Ha Biological Technology (BYAH) has reported Long-Term Investments for 4 consecutive years, with $3.5 million the latest figure, recorded in Q2 2026.

• Quarterly Long-Term Investments rose 57.11% year-over-year to $3.5 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $3.5 million (up 57.11% YoY) and the FY2025 annual result came in at $3.7 million, up 97.72% from the prior year.
• Long-Term Investments fell to $3.5 million in Q2 2026 per BYAH's latest filing, from $3.7 million in the prior quarter.
• Over the last five years, Long-Term Investments for BYAH reached as high as $3.7 million in Q4 2025 and fell as low as $1.0 million in Q4 2023.
• A 4-year average of $2.5 million and a median of $2.2 million in 2025 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2025 — Long-Term Investments soared 97.72% — and 2026, when it soared 57.11%.
• Year by year, Long-Term Investments stood at $1.0 million in 2023, then jumped by 85.63% to $1.9 million in 2024, then surged by 97.72% to $3.7 million in 2025, then dropped by 6.26% to $3.5 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $3.5 million, $3.7 million, and $2.2 million for Q2 2026, Q4 2025, and Q2 2025 respectively.